Tear Trough and Under-Eye Shadow Treatment in Marylebone, London

Only if the shadow is primarily volumetric. If pigment or skin quality is driving the shadow, filler alone will under-deliver and may even worsen the appearance by changing how light catches the area. The consultation tests for all three mechanisms — many patients leave with a plan that combines polynucleotides for skin quality with a smaller dose of filler for residual hollowing, rather than filler alone.

It is one of the higher-vascular-risk aesthetic sites because of the proximity of the angular and infraorbital arteries. Risk is reduced by cannula technique, conservative low-pressure injection, and a clinician with detailed knowledge of periorbital anatomy. Dr Oli's surgical anatomy training (MRCS, Royal College of Surgeons of England) is directly relevant. Hyaluronidase is stocked on-site for immediate dissolution if needed.

Typically 12 to 15 months because the under-eye area moves less than other facial sites. The HA used here (typically Restylane Defyne or a similarly low-water-affinity product) is selected specifically to integrate cleanly without producing the bluish "Tyndall effect" that more hydrophilic products can cause in thin lower-eyelid skin.

Then filler is the wrong answer entirely. The treatment plan in this case combines a topical regimen (vitamin C, retinoid, sunscreen, possibly hydroquinone if appropriate) with in-clinic IPL or laser sessions. Occasionally referral to a dermatologist or oculoplastic surgeon is the right call if the underlying cause is structural rather than aesthetic.

For skin-quality-driven under-eye shadows — thin crepey lower-eyelid skin — yes. Three sessions three weeks apart show visible thickening and improved light reflection by week 8. Photo documentation at every visit makes the change measurable. Results peak at week 12 and last around 6 months; maintenance every 4 to 6 months sustains the effect.